Atomo Diagnostics Share Price and Company Fundamentals



Price
$0.076
Change
0.001 (1.333%)
52 week
0.056 - 0.3725

Last traded: Today at 6:10 AM

Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing in Australia and internationally. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Key Metrics

PE ratio

-

PB ratio

1.54

Dividend yield

0.00%

Beta

1.16

Market cap

-

Enterprise value

-

Company profile

Primary activitiesThe expansion of global sales and continued development of its rapid test device technologies.
Industry / SectorMedical Devices / Healthcare
Websitehttps://atomodiagnostics.com
Mailing address701-703 Parramatta Road Level 2 Leichhardt NSW 2040 Australia
Phone / Fax61 2 9099 4750 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

More: Atomo Diagnostics Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Atomo Diagnostics paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AT1 dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AT1's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Atomo Diagnostics.

NameTitleAgeTotal Pay
Mr. John Michael KellyFounder, CEO, MD & Director499.72k
Mr. William Edward Souter BCom, LLB (Adel), IPAAChief Financial Officer352.53k
Ms. Chandra SukumarChief Operating Officer
Mr. Jim P. McMenamyHead of Bus. Devel. & Partnerships of the Americas
Ms. Anna TuckerHead of Bus. Devel. & Partnerships of Europe, Middle East and Africa
Mr. Tharun KuppandaCompany Sec.

Profitability and management effectiveness

Profit margin

-78.81%

Operating margin

-74.09%

Return on assets

-10.65%

Return on equity

-19.33%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Atomo Diagnostics is and its enterprise value is .

The AT1's stocks Beta value is 1.16 making it 16% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Atomo Diagnostics (AT1)

Atomo Diagnostics (ASX:AT1) Frequently Asked Questions

1. What is Atomo Diagnostics's Stock Symbol?

Atomo Diagnostics trades on ASX under the ticker symbol "AT1".

2. What is Atomo Diagnostics's stock price today?

One share of AT1 stock can currently be purchased for approximately $0.076.

3. How can I contact Atomo Diagnostics?

Atomo Diagnostics's mailing address is 701-703 Parramatta Road Level 2 Leichhardt NSW 2040 Australia. The company can be reached via phone at 61 2 9099 4750.

4. What is Atomo Diagnostics's official website?

The official website of Atomo Diagnostics is https://atomodiagnostics.com.

5. Which share registry manages Atomo Diagnostics's stock?

Atomo Diagnostics's stock is managed by LINK MARKET SERVICES LIMITED.